Home › Funds › Atle Fund Management AB › ABVX

Atle Fund Management AB position in ABVX

Abivax SA · Health Care

Atle Fund Management AB reported holding 46,452 shares of ABVX (Abivax SA) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 1.23% of its reported portfolio and ranking #29 among its reported holdings. Atle Fund Management AB has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)46.45K sh
Reported value held$4.60M
Portfolio Weight1.23%
First reportedQ4 2025
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's ABVX position evolved

Atle Fund Management AB first disclosed a stake in ABVX in Q4 2025 at 31,590 shares (US$4.3M). The position peaked in Q2 2026 at 58,170 shares, worth US$7.8M. Across 4 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 46,452 shares valued at US$4.6M — a reduction of -11,718 shares quarter over quarter.. Notable position changes include a 84% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 31.59K $4.26M New
Q1 2026 31.59K $4.78M Hold
Q2 2026 58.17K $7.75M Add
Q3 2026 46.45K $4.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (Abivax SA) is a Health Care company. 73 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Atle Fund Management AB held ABVX?

Atle Fund Management AB has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Atle Fund Management AB's current position in ABVX?

As of Q3 2026, Atle Fund Management AB holds 46.45K shares of ABVX (Abivax SA), valued at $4.60M, representing 1.23% of its reported portfolio and ranking #29.

Has Atle Fund Management AB been buying or selling ABVX?

In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in ABVX. The position peaked in Q2 2026 at 58.17K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.